nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to antibiotics: not a problem in some LMICs
|
Sulis, Giorgia |
|
|
9 |
5 |
p. e561-e562 |
artikel |
2 |
Addressing the disconnect between trial intention and design
|
Howie, Alison |
|
|
9 |
5 |
p. e577-e578 |
artikel |
3 |
An interactive website tracking COVID-19 vaccine development
|
Shrotri, Madhumita |
|
|
9 |
5 |
p. e590-e592 |
artikel |
4 |
Antiretroviral therapy dispensing for patients who are clinically stable
|
Sibanda, Euphemia |
|
|
9 |
5 |
p. e565-e566 |
artikel |
5 |
Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka
|
Finkelstein, Eric A |
|
|
9 |
5 |
p. e660-e667 |
artikel |
6 |
Challenges in interpreting SARS-CoV-2 serological results in African countries
|
Nkuba Ndaye, Antoine |
|
|
9 |
5 |
p. e588-e589 |
artikel |
7 |
Challenges of adopting new trial designs in LMICs
|
Bhandari, Nita |
|
|
9 |
5 |
p. e575-e576 |
artikel |
8 |
Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach
|
Do, Nga T T |
|
|
9 |
5 |
p. e610-e619 |
artikel |
9 |
Correction to Lancet Glob Health 2020; 8: e452–53
|
|
|
|
9 |
5 |
p. e597 |
artikel |
10 |
Correction to Lancet Glob Health 2020; published online Feb 28. https://doi.org/10.1016/S2214-109X(20)30074-7
|
|
|
|
9 |
5 |
p. e597 |
artikel |
11 |
Correction to Lancet Glob Health 2021; published online Feb 17. https://doi.org/10.1016/S2214-109X(21)00060-7
|
|
|
|
9 |
5 |
p. e597 |
artikel |
12 |
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial
|
Thomas, Ranjeeta |
|
|
9 |
5 |
p. e668-e680 |
artikel |
13 |
Cost-effectiveness of universal HIV testing and treatment: where next?
|
Nachega, Jean B |
|
|
9 |
5 |
p. e573-e574 |
artikel |
14 |
COVID-19 intra-action reviews: potential for a sustained response plan
|
Greiner, Ashley L |
|
|
9 |
5 |
p. e594 |
artikel |
15 |
COVID-19 serosurveys for public health decision making
|
Murhekar, Manoj V |
|
|
9 |
5 |
p. e559-e560 |
artikel |
16 |
Disseminating public health messages about second-hand smoking through mosque congregations in Bangladesh
|
Ahmed, Sayem |
|
|
9 |
5 |
p. e567-e568 |
artikel |
17 |
Effect of a Birthing on Country service redesign on maternal and neonatal health outcomes for First Nations Australians: a prospective, non-randomised, interventional trial
|
Kildea, Sue |
|
|
9 |
5 |
p. e651-e659 |
artikel |
18 |
Efficacy and cost-effectiveness of a community-based smoke-free-home intervention with or without indoor-air-quality feedback in Bangladesh (MCLASS II): a three-arm, cluster-randomised, controlled trial
|
Mdege, Noreen Dadirai |
|
|
9 |
5 |
p. e639-e650 |
artikel |
19 |
How COVID-19 has fundamentally changed clinical research in global health
|
Park, Jay J H |
|
|
9 |
5 |
p. e711-e720 |
artikel |
20 |
Implementation of dual maternal HIV-Syphilis testing: The devil is in the details
|
Broyles, Laura N |
|
|
9 |
5 |
p. e595 |
artikel |
21 |
Innovations for effective implementation of guideline-based hypertension care in low-income and middle-income countries
|
Naik, Nitish |
|
|
9 |
5 |
p. e571-e572 |
artikel |
22 |
Malaria in Venezuela: Gabaldón's legacy scattered to the winds
|
Gabaldón-Figueira, Juan C |
|
|
9 |
5 |
p. e584-e585 |
artikel |
23 |
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial
|
Hoffman, Risa M |
|
|
9 |
5 |
p. e628-e638 |
artikel |
24 |
Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer
|
Rodriguez, Natalia M |
|
|
9 |
5 |
p. e582-e583 |
artikel |
25 |
Poverty, precarious work, and the COVID-19 pandemic: lessons from Bolivia
|
Hummel, Calla |
|
|
9 |
5 |
p. e579-e581 |
artikel |
26 |
Pregnant women's appetite for risk
|
Vassallo, Amy |
|
|
9 |
5 |
p. e593 |
artikel |
27 |
Progressing the investment case in maternal and child health
|
The Lancet Global Health, |
|
|
9 |
5 |
p. e558 |
artikel |
28 |
Providing the right tools before the start of life
|
Brown, Kiarna |
|
|
9 |
5 |
p. e569-e570 |
artikel |
29 |
Randomised trials at the level of the individual
|
Park, Jay J H |
|
|
9 |
5 |
p. e691-e700 |
artikel |
30 |
Redesigning and delivering inclusive parenting interventions for fathers
|
Jeong, Joshua |
|
|
9 |
5 |
p. e596 |
artikel |
31 |
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
|
Chen, Xinhua |
|
|
9 |
5 |
p. e598-e609 |
artikel |
32 |
The conundrum of a global tool for early childhood development to monitor SDG indicator 4.2.1
|
Olusanya, Bolajoko O |
|
|
9 |
5 |
p. e586-e587 |
artikel |
33 |
The optimum implementation of long-acting injectable cabotegravir–rilpivirine in sub-Saharan Africa
|
Dawood, Halima |
|
|
9 |
5 |
p. e563-e564 |
artikel |
34 |
The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
|
Phillips, Andrew N |
|
|
9 |
5 |
p. e620-e627 |
artikel |
35 |
The role and challenges of cluster randomised trials for global health
|
Dron, Louis |
|
|
9 |
5 |
p. e701-e710 |
artikel |
36 |
Urgently seeking efficiency and sustainability of clinical trials in global health
|
Park, Jay J H |
|
|
9 |
5 |
p. e681-e690 |
artikel |